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Abstract: Children are particularly vulnerable to environmental tobacco smoke (ETS). There is no
routine support to reduce ETS in the home. We systematically reviewed trials to reduce ETS in children
in order to identify intervention characteristics and behaviour change techniques (BCTs) to inform
future interventions. We searched Medline, EMBASE, CINAHL, PsycINFO, ERIC, Cochrane Central
Register of Controlled Trials, and Cochrane Tobacco Addiction Group Specialised Register from
January 2017 to June 2020 to update an existing systematic review. We included controlled trials
to reduce parent/caregiver smoking or ETS in children <12 years that demonstrated a statistically
significant benefit, in comparison to less intensive interventions or usual care. We extracted trial
characteristics; and BCTs using Behaviour Change Technique Taxonomy v1. We defined “promising”
BCTs as those present in at least 25% of effective interventions. Data synthesis was narrative.
We included 16 trials, of which eight were at low risk of bias. All trials used counselling in
combination with self-help or other supporting materials. We identified 13 “promising” BCTs centred
on education, setting goals and planning, or support to reach goals. Interventions to reduce ETS in
children should incorporate effective BCTs and consider counselling and self-help as mechanisms
of delivery.
Keywords: systematic review; behaviour change techniques; smoking; harm reduction;
second-hand smoke; tobacco smoke pollution; postnatal; children
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1. Introduction
Smoking has a severe detrimental impact on parental and child health [1]. Exposure to
environmental tobacco smoke (ETS) from parents or caregivers increases rates of sudden infant
death syndrome, respiratory conditions, and other infections [2]. Children are more susceptible
to second-hand smoke than adults are [3,4], particularly vulnerable children, such as premature
infants [5]. Exposure to smoke in early life results in increased morbidity throughout childhood and
into adulthood [2,6,7]. Children exposed to tobacco smoke in utero or in early life are more likely to be
admitted to paediatric care, or to a neonatal intensive care unit (NICU) [8,9], resulting in significant
economic burden [10–13]. In the U.K., the annual cost of smoking in pregnancy is estimated to be
£64 million for treating maternal health problems and a further £23.5 million for treating infants [14].
Pregnant women and parents are motivated to quit smoking for the health of their children [15,16],
but smoking relapse rates are high [17], particularly post-birth [18,19]. Living with a smoking partner
or other smoking household member and stress, which may arise from increased parenting demands
or lack of sleep, increase the likelihood of relapsing to smoking postpartum [20]. Smoking prevalence
is also higher in lower socioeconomic groups [1]. For parents able to remain abstinent and for never
smokers, maintaining a smoke-free environment is still challenging when there are other family or
household members who smoke [15].
The birth of a child offers a “teachable moment” to support smoke-free environments [21–23].
National guidance recommends support for smoke-free strategies in secondary care settings during
pregnancy and after childbirth [24–26]. However, interventions to maintain smoke-free environments
are not routinely offered in paediatric settings or in the home environment [26–28]. Support is
particularly limited for very vulnerable children, such as those admitted to a NICU, where support to
maintain a smoke-free environment is especially crucial [22,29]. Evidence of effective interventions
to reduce environmental tobacco smoke (ETS) in young children is limited. A review of smoking
cessation in pregnancy and into the postpartum period [19] found some evidence for success of
counselling, health education, and incentives, for 0 to 17 months postpartum, but no effect beyond this.
A systematic review of interventions to reduce tobacco smoke pollution in homes found that, overall,
interventions trialled did improve tobacco smoke air pollution but did not link effectiveness to “type”
of intervention [30]. A Cochrane review [27], determining the effectiveness of reducing exposure of
children aged 0 to 12 years to ETS, found a minority of interventions reduced exposure, and the features
that differentiated effective from ineffective interventions remain unclear [27]. Behaviour change
interventions are complex by nature, comprising multiple components such as mechanisms of
delivery in addition to behaviour change techniques (BCTs) [31]. By identifying BCTs within effective
interventions, it may be possible to specify what components might be combined to develop more
successful interventions [32]. No previous reviews have identified BCTs to reduce ETS exposure in
young children or have drawn firm conclusions of effective mechanisms of delivery. Behbod et al. [27]
conducted literature searches up to February 2017, and updating this review might identify new and
effective interventions. We aimed to systematically review controlled trials aiming to reduce the ETS
exposure of children aged under 12 years, to identify promising mechanisms of intervention delivery
and BCTs to inform future interventions. Our review was registered on the Open Science Framework
on 23 May 2019 and was updated on 22 January 2020 (https://osf.io/zhmtu/).
2. Materials and Methods
2.1. Approach
This systematic review is guided by the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines [33]. First, we updated an existing systematic review of controlled
trials to reduce children’s exposure to ETS [27]. We then identified interventions with evidence of a
statistically significant positive effect from identified trials. Finally, we identified BCTs [32] described
within these effective interventions.
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2.2. Search Strategy
We searched Medline (OvidSP), EMBASE (OvidSP), CINAHL (EbscoHOST), PsycINFO (OvidSP),
ERIC (ProQuest), Cochrane Central Register of Controlled Trials, and the Cochrane Tobacco Addiction
Group Specialised Register from 1 January 2017 to 11 June 2020. We replicated the search strategy
used by Behbod et al. to update their systematic review [27]. Keywords included the following:
parent, caregiver, family, house, home, newborn, infant, child, tobacco, smoking, smoking cessation,
environmental pollution, and tobacco smoke pollution. The full search strategy is published in Behbod
et al. [27]. Effective trials published prior to 2017 were identified by handsearching Behbod et al. [27].
Reference lists of included trials were also searched for any relevant articles. We attempted to
contact authors of all included trials to collect all published or unpublished details of the intervention
methodology and any further trial evaluation data (e.g., study acceptability or feasibility).
2.3. Trial Selection
We included controlled trials (randomised and non-randomised as in Behbod [27]) to reduce the
ETS exposure of families with young children. Participants were parents or caregivers of children
aged under 12 years of age. We included trials where the primary aim was to either reduce children’s
exposure to ETS, or reduction or cessation of parent or caregiver smoking, versus another intervention
or usual care. We included trials with a follow-up period of 6 months or more. Since our focus
was on interventions for parents or caregivers that would be suitable to use in any child under
12 years, we excluded trials which included any child ≥12 years, or trials in which children undertook
any intervention activities themselves (e.g., parent/child dyads), or trials that included school-based
(or other educational establishment) intervention activities. Trials not published in English were also
excluded due to the detailed nature of identifying BCTs [32]. We aimed to identify promising BCTs,
thus we included only trials that were “effective” at long-term follow-up (6 months or more from
baseline), defined as “a reported statistically significant p value of <0.05, with ETS exposure or smoking
status of household members as the primary outcome (whether or not biochemically validated)”.
Two authors (two from T.J.B., S.G., or C.N.) independently screened citations on the basis of title
and abstract using Covidence software and also using tables of study characteristics published in
Behbod et al. when hand-searching [27]. Any disagreements were resolved by consensus. Where it
was unclear whether a study met our inclusion criteria, the full text was collected and assessed in
duplicate. Each full-text article was assessed for inclusion using an inclusion log within Covidence,
and reasons for study exclusion were also recorded.
2.4. Data Extraction
Trial characteristics for both the intervention and control groups were extracted into a tailor-made
Excel sheet to include the following: trial design, participants, sample size, country, details of
the intervention and control procedures, behavioural theory, outcome measures, smoking outcomes,
and process indicators. Our smoking outcomes were ETS exposure (as defined by authors), and smoking
status of family or household members. Additional outcome measures were acceptability, feasibility,
child health outcomes (e.g., respiratory illness, use of health services), and behaviour change
(e.g., implementation of a household smoking ban).
We used Behaviour Change Technique Taxonomy v1 (BCTTv1) [32] to extract BCTs from
intervention and control descriptions of all included articles (the main paper and associated articles
as relevant for each trial). We extracted BCTs that targeted smoking cessation, smoking relapse,
or behaviours relating to a reduction of ETS. BCT codes were assigned to relevant sections of articles
and were extracted if definitely (coded ++) or probably (coded +) present following BCTTv1 principles
(www.bct-taxonomy.com). These principles define a coding of ++ as a “BCT present beyond all
reasonable doubt”, and a coding of + as a “BCT present in all probability”. We calculated the frequency
of BCTs from intervention groups across all effective trials to identify “promising” BCTs that might
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improve intervention success. In the absence of a gold standard approach [34], we sought BCTs based
on prevalence within intervention groups [35]. We defined “promising” BCTs as those present in at
least 25% of effective interventions [36].
Data were extracted independently by two BCTTv1-trained researchers. Researchers met to
agree on findings, with any disagreements resolved through discussion or the involvement of a third
researcher. We did not undertake any statistical analysis due to the wide range of interventions
to reduce environmental tobacco smoke and the diversity in populations, settings and outcomes.
Data synthesis was narrative.
2.5. Quality Assessment
Two researchers (two from T.J.B., S.G., or C.N.) independently assessed the risk of bias for all
included studies. Risk of bias was categorised as high, low, or unclear for the following domains:
“random sequence generation”, “allocation concealment”, “incomplete outcome data”, “blinding of
participants and personnel”, “blinding of outcome assessment”, and for any other bias (e.g., funding)
in accordance with the Cochrane Handbook for Systematic Reviews of Interventions [37]. In addition to
assessing each of these domains separately, a judgement of overall risk of bias for each trial was reached
by consensus among three reviewers (T.J.B., S.G., and C.N.). Since full blinding of the intervention
in these trials is not possible due to the nature of their design, we excluded “blinding of participants
and personnel” from our overall risk of bias assessment. For the remaining domains, where at least
three out of five domains were at low, unclear or high risk of bias, our overall judgement for risk
of bias was low, unclear, or high, respectively. Where at least one domain was at high risk of bias,
our overall judgement for risk of bias was automatically downgraded to at least a status of unclear.
Any disagreements were resolved through discussion.
3. Results
3.1. Numbers of Trials
The inclusion of controlled trials is shown in Figure 1. Electronic and hand searching identified
550 records, with 493 references remaining after the removal of duplicates. Based on title and abstract
screening, 103 relevant articles were retrieved for full-text assessment, with the final inclusion of
16 primary controlled trials [5,38–52] (associated with 41 articles, Table S1). Twelve of these trials had
previously been identified by Behbod and colleagues [27]. We also identified one relevant ongoing
trial [53]. Despite writing to all authors of the included studies, only five responded to our request for
further information, of which two supplied information we had not already identified (a published
protocol [49]; and a report to study funders [41]).
3.2. Trial Characteristics
Fifteen trials aimed to promote smoke-free environments alongside encouraging smoking cessation
or abstinence. One trial [44] was designed to promote a smoke-free environment without emphasising
smoking cessation or abstinence. Full trial characteristics are shown in Table S2 (including population,
sample size, details of the intervention and control, outcome measures, and process indicators).
Twelve trials [5,38,39,41,42,44–49,52] were randomised controlled trials (RCTs), three were cluster
RCTs [40,50,51], and one was a non-randomised controlled trial [43]. Most trials were conducted
in the USA [5,40,42–45,47–49,51], with the remaining trials in China [38,39,41,52], Germany [46],
and Spain [50]. Six trials were conducted exclusively in neonates [5,43,44,46,51,52], two in young infants
(0–18 months) [41,50], five in children aged up to 5 years [38,39,42,47,48], and three in children aged
up to 12 years [40,45,49]. Nine trials recruited both parents/caregivers [5,38–42,49,50,52], and seven
trials [43–48,51] recruited mothers/female caregivers only. Ten trials recruited smokers or recent
quitters [38–40,42,45–51], two had mixed populations of non-smokers or smokers [5,44], one focussed
on postpartum quitters [43], and two recruited families with a smoking father and non-smoking
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mother [41,52]. One trial [5] recruited specifically via neonatal intensive care units. Other recruitments
were via community health settings [38,39,41,42,47,48,52], hospitals post-delivery [43,44,46,51],
paediatric care [49,50], primary care [45], or schools [40]. Five trials [42,45,47–49] recruited specifically
from low-income or minority group areas.
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Figure 1. Flow diagram.
3.3. Intervention Characteristics
Trials used various different theoretical approaches and modes of delivery. Interventions were
generally a combination of “counselling” (e.g., motivational interviewing, cognitive behavioural
therapy, or counselling based on behaviour change theories) and the provision of self-help or
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educational materials. Five trials used only this combination [38,39,46,49,50]. Other trials used
this combination in conjunction with the provision of nicotine replacement therapy [40,41,48],
or the provision of objects or reminders, such as stickers and signs to request a smoke-free
environment [43–45,47,51]. Two trials provided feedback on smoking outcomes to parents/caregivers
as part of the intervention (infant salivary cotinine [5]; or air nicotine, caregiver carbon monoxide
levels, and respiratory symptoms [42]) in addition to counselling and self-help materials. One trial
added supportive text messages to one of the intervention arms [52]. Control groups received
less intensive interventions [39,41,42,46,47,49,51], less smoking information [5,38,40,43,45], or usual
care (generally brief advice) [44,48,50,52]. Intervention delivery was usually through a combination
of in-person and telephone contacts, but six trials provided counselling in-person [44,45,50–52]
or by telephone only [39]. Counselling was delivered by nurses [5,39,41,43–45], student or
graduate counsellors [47–49], health workers [38,42,52], primary care staff [50], paediatric staff [51],
or general trained counsellors [40,46]. Interventions varied from the provision of a single counselling
session [45] to up to 14 sessions [48] (mean 5 sessions). Not all trials reported session lengths,
but where reported, session length also differed widely between trials from 2 min [51] up to
45 min [5,38,42,44,46]. Intervention duration varied from 1 month to 2 years, with six trials
intervening for 6 months or longer [40,44,48,50–52]. There was no clear pattern to indicate
which intervention intensity or duration would be the most advantageous. Six included trials
measured outcomes at 6 months post-enrolment [38,39,42,43,45,50] and ten measured outcomes
beyond 6 months [5,40,41,44,46–49,51,52], with the longest study [40] assessing outcomes for up to
4 years.
3.4. Quality Assessment
Eight studies were considered at low risk of bias [5,39–42,47,49,51], six at unclear
risk [38,44,45,48,50,52], and only two were considered at high risk of bias [43,46]. Blinding of
participants and personnel was either at high or unclear risk for all studies and, therefore, overall risk of
bias would be higher if we had included this within our assessment. Some trials reported acceptability
and/or fidelity concerns, and we considered three trials as having more major acceptability and/or
fidelity concerns [41,43,46]. Specifically, these trials reported fidelity issues: practical difficulties in
delivering the on-site component of the intervention due to “noisy” and “congested” environments in
some clinics [41]; inconsistent delivery of intervention elements, such as nurses being significantly
less likely to discuss pharmacological options with abstinent women [43]; and a low adherence to the
motivational interview protocol with only 38% of sessions showing good adherence [46]. Many trials
failed to adequately report evaluation of feasibility (acceptability, fidelity, and/or other process indicators,
e.g., verification of parent self-report), suggesting that more trials may have suffered from feasibility
issues. The majority of our included trials included a form of biochemical outcome validation.
Most used exhaled carbon monoxide or salivary/urinary cotinine concentration [5,38–44,47–49].
Three of these trials also used air nicotine monitoring [42,47,48]. One trial used only infant hair nicotine
concentration [50]. Four trials [45,46,51,52] did not include any biochemical validation.
3.5. Behaviour Change Techniques
We identified a wide range of BCTs targeting smoking cessation, smoking relapse, or behaviours
relating to a reduction of ETS as summarised in Table 1 and detailed (coded as probably +, or definitely
++ present) for each separate trial in Table S2. The majority of BCTs were delivered to intervention
rather than to control groups. The number of BCTs identified in control groups for each trial ranged
from 1 [38,40,47] to 3 [41], with an average of 0.5 BCTs. A total of 6 of the 93 BCTs were found in
control groups. In comparison, the number of BCTs identified in intervention groups for each trial
ranged from 3 [51] to 16 [42,46], with an average of 9 BCTs. Study protocols or description of study
designs were available for seven trials (six published [42,44,46,49–51], one a study report supplied by
authors [41]), and the number of BCTs identified in interventions were higher in these trials. A total of
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42 of the 93 BCTs from BCTTv1 were found in interventions, and at least one BCT was present from
each of the 16 BCT clusters in intervention groups [32]. Most BCTs in intervention groups were found
in the “goals and planning” cluster, which focuses on goal setting, problem solving, action planning,
and review of goals.
Table 1. Frequency of behaviour change techniques (BCTs) identified in interventions to reduce
environmental tobacco smoke.
BCT Code BCT Label
BCT in Effective
Interventions
n (% Studies); Max n = 16
1.1 Goal setting (behaviour) 8 (50) *
1.2 Problem solving 11 (69) *
1.4 Action planning 8 (50) *
1.5 Review behaviour goal(s) 6 (38) *
1.6 Discrepancy between current behaviour and goal 1 (6)
1.7 Review outcome goal(s) 1 (6)
1.8 Behavioural contract 2 (13)
2.2 Feedback on behaviour 3 (19)
2.3 Self-monitoring of behaviour 3 (19)
2.6 Biofeedback 3 (19)
2.7 Feedback on outcome(s) of behaviour 1 (6)
3.1 Social support (unspecified) 13 (81) *
3.2 Social support (practical) 2 (13)
4.1 Instruction on how to perform a behaviour 7 (44) *
5.1 Information about health consequences 10 (63) *
5.2 Salience of consequences 1 (6)
5.3 Information about social and environmentalconsequences 4 (25) *
5.6 Information about emotional consequences 1 (6)
6.1 Demonstration of the behaviour 1 (6)
6.2 Social comparison 1 (6)
7.1 Prompts/cues 2 (13)
8.2 Behaviour substitution 4 (25) *
8.7 Graded tasks 1 (6)
9.1 Credible source 9 (56) *
9.2 Pros and cons 3 (19)
10.4 Social reward 7 (44) *
10.9 Self-reward 2 (13)
11.1 Pharmacological support 3 (19)
11.2 Reduce negative emotions 3 (19)
12.1 Restructuring the physical environment 2 (13)
12.2 Restructuring the social environment 2 (13)
12.3 Avoidance/reducing exposure to cues for the behaviour 2 (13)
12.5 Adding objects to the environment 5 (31) *
13.1 Identification of self as role model 1 (6)
13.2 Framing/reframing 2 (13)
13.3 Incompatible beliefs 1 (6)
13.5 Identity associated with changed behaviour 1 (6)
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Table 1. Cont.
BCT Code BCT Label
BCT in Effective
Interventions
n (% Studies); Max n = 16
14.4 Reward approximation 3 (19)
15.1 Verbal persuasion about capability 4 (25) *
15.2 Mental rehearsal of successful performance 1 (6)
15.3 Focus on past success 2 (13)
16.2 Imaginary reward 1 (6)
* Effective BCT (in ≥25% studies).
“Promising” BCTs, using our criterion of occurring in at least 25% of intervention groups
(excluding those delivered to both intervention and control groups), were the following: social support
unspecified (81%), problem solving (69%), information about health consequences (63%), credible source
(56%), goal setting behaviour (50%), action planning (50%), social reward (44%), instruction on how
to perform a behaviour (44%), review behaviour goals (38%), adding objects to the environment
(31%), behaviour substitution (25%), verbal persuasion about capability (25%), and information
about social and environmental consequences (25%). Of these BCTs common to intervention groups,
all included more ++ (definitely present) than + (probably present) codes, with the exception of
“credible source” and “review behaviour goals”. We are therefore less certain of classifying these
two BCTs as “promising”. However, neither of these BCTs were delivered to control groups. Of the
“promising” BCTs, only “information about social and environmental consequences”, “instruction on
how to perform a behaviour”, and “behaviour substitution” occurred in control groups, but occurrence
was at a lower frequency (19%, 6%, and 6%, respectively). The most common BCT delivered to control
groups was “information about social and environmental consequences”. We found no distinct pattern
in BCTs based on trial variables, such as whether assessment was biochemically validated or not.
We also found no clear pattern as to which BCTs would be the best to deliver to different populations.
4. Discussion
We included 16 controlled trials that were effective in reducing children’s exposure to ETS.
Our review has updated and advanced evidence from Behbod et al. (2018), a Cochrane review
of smoking control programmes for reducing exposure to ETS in children aged 0–12 years [27].
These authors did not find a clear link between intervention features and study effectiveness.
Similarly, earlier reviews of interventions to promote smoke-free home environments for children aged
0–5 years [54] and a review of routine healthcare interventions to reduce tobacco smoke exposure in
children aged 0–12 years [55] concluded that further research was required to identify effective elements
of interventions. Rosen et al. [30] found some evidence of benefit for interventions to protect children
(0–12 years) from tobacco smoke exposure but did not specify which intervention type was most effective.
Our review found that effective interventions all used some form of “counselling” supplemented with
self-help or other materials, compared to less intensive “counselling” and fewer support materials
in control groups. We did not set out to compare effective with non-effective trials; we aimed
to investigate characteristics of intervention and control groups within effective trials, to identify
promising mechanisms of intervention delivery. A review of prevention of postpartum smoking
relapse, also found that effective trials provided self-help mainly in conjunction with counselling [36].
A systematic review for smoking cessation in pregnancy and into the postpartum period similarly
found some evidence for a beneficial impact of counselling and, to a lesser extent, health education [19].
In contrast to our present review, these authors also found a beneficial effect of using incentives.
We suggest that interventions using counselling and self-help approaches, potentially in conjunction
with other elements, are most likely to be effective. Interventions that we included in our present
review were most commonly delivered by health professional counsellors, in-person or by telephone.
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No previous reviews have aimed to identify effective BCTs to reduce ETS in young children.
We identified 13 “promising” BCTs, which focused on social support from health professionals,
goals and planning, information giving from a credible source, and developing strategies to aid
smoking cessation, prevent relapse, or to promote smoke-free environments. Previous reviews using
BCTTv1 [32] to identify effective BCTs for smoking relapse in the postpartum period [36] and for
smoking cessation in pregnancy [56] also found problem solving, information giving, and social
support to be important. The most frequent BCT we identified in the present review was social
support. Social support, particularly from partners, is recognised as a key barrier or facilitator in
smoking cessation and remaining smoke free [16,57]. However, seven of our included trials [43–48,51]
recruited only mothers or female caregivers. We found BCTs in the cluster of “goals and planning”
to be most frequently used in our included effective interventions. This cluster includes advice on goal
setting and strategies to overcome barriers to reach and maintain goals. Parents with younger infants,
or with vulnerable children under paediatric care, or admitted to a NICU are under considerable acute
and chronic stress [58–61], which likely acts as a barrier to creating and maintaining a smoke-free
environment [15,16,20] and should be taken into consideration to aid goal setting and strategies to
remain smoke free. Self-efficacy and ability to implement successful strategies is related to the BCT
“verbal persuasion about capability” [32], which we identified as commonly occurring in effective
interventions. For smoking parents, lower confidence to remain smoke-free, is a predictor of relapse [20],
which this BCT may address. We identified information giving to be a key BCT to address smoking
cessation, smoking relapse, or reduction of ETS. Parental smoking increases risk of child respiratory
and other health conditions [2]. However, there are gaps in the knowledge base of parents and
health professionals of the dangers of second-hand smoke [15,28,58] and how health professionals
can effectively communicate these dangers to parents [15,28]. We found information provided from
a “credible source” to be one of our “promising” BCTs. Belief of source credibility impacts attitudes
and behaviour change, over and above attitudes about the validity of the information itself [62] and
credibility may be particularly important for new parents, postpartum parents, or on admission of a
child to paediatric care when parents are reliant on advice from health professionals.
Strengths of this review were undertaking comprehensive searches, full independent duplication
of screening and data extraction, and the inclusion of a third reviewer to resolve any discrepancies.
We included unpublished data from trials when made available by study authors.
Potential limitations to this review were incomplete reporting of BCTs in included studies.
Study protocols or description of intervention designs were only available for seven trials [41,42,44,46,49–51],
and these trials contained more BCTs. A review of BCTs in smoking cessation interventions has also
found that fewer BCTs are described in published sources compared to those in unpublished data [63].
This may be particularly true for interventions using detailed components such as text message
support [52]. We therefore took an inclusive approach to identifying BCTs, including those both
probably (+) and definitely (++) present [32] to ensure any relevant BCTs were identified. We did
not compare differences in BCTs across smoking behaviours (smoking cessation, smoking relapse
prevention, or reduction in ETS) since studies largely targeted these behaviours together. BCTs within
control conditions are particularly poorly described in published literature [63], and we did not
compare BCTs in intervention groups with BCTs delivered to control groups, since so few BCTs were
identified as being delivered exclusively to control groups. We did not conduct any statistical or
subgroup analysis or assess which BCTs were associated with greater effect sizes, due to the small
number of studies identified and diversity in populations, interventions, and outcomes reported [34,64].
Data synthesis was narrative and focused on components of effective interventions, an approach used
in similar reviews [34–36,56]. We did not aim to compare BCTs within effective and non-effective trials;
we aimed to explore which BCTs were common in effective interventions and which mechanisms of
intervention delivery were commonly used, to give an indication of how BCTs might be best delivered,
as a starting point to develop an intervention with optimal impact. There is no standard approach to
identifying effective BCTs [34]. We defined “promising” BCTs as occurring in at least 25% of effective
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intervention studies [36]. We cannot definitively show any causal relationship with trial outcome for
particular BCTs or mechanisms of delivery. However, the repeated presence of these components
across effective interventions suggests these components might be the more promising ones to include
in future interventions. In other words, “to identify the right intervention, for the right population at
the right time”.
The majority of our trials were at low risk of bias, although we identified some feasibility concerns
that might have limited our findings. It is likely there were additional feasibility issues that we were
unaware of as reporting was inadequate in many trials. Most included trials were in high-income
countries, but a third recruited from low-income areas, where smoking prevalence and exposure to ETS
are likely to be higher [65]. We identified no U.K. trials. Most included trials were conducted in the
U.S., where the healthcare system differs markedly from that in European countries. Previous reviews
have found few smoking interventions in very vulnerable infants, such as NICU populations [27,30].
Indeed, only one of our included studies recruited specifically from a NICU [5]. We also found limited
reporting of process measures within trials. The majority of trials included biochemical validation,
but four [45,46,51,52] did not. We identified only one intervention using digital support in the form
of text messages [52]. No other trials used newer harm reduction approaches such as e-cigarettes or
other types of digital support (such as mobile apps), which have the potential to provide support in a
more cost-effective manner. However, we identified one ongoing trial [53] that is using counselling
in combination with nicotine replacement therapy, a mobile app, and texts; although this study is
relatively small, aiming to recruit 149 participants per group. Many interventions to reduce ETS in
children are short in duration and were therefore not included in this review. Further interventions
incorporating newer approaches and holistic family support and with a duration of at least 6 months
may be of benefit in the future. We recommend that studies better describe details of intervention
mechanisms to enable further investigation of effective components, such as which BCTs would be
most suited to particular populations.
5. Conclusions
There is a gap in knowledge regarding how best to reduce ETS exposure in young children,
particularly for children in vulnerable groups. This review found that interventions effective in
reducing ETS were delivered using counselling in combination with self-help materials and most
commonly used BCTs involving education, goal setting and planning, and support to reach goals.
Future interventions should consider these approaches to improve the chances of reducing child
exposure to ETS, generating health and economic benefits for families and for wider society.
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